Range
- - -
Vol / Avg.
-/-
Div / Yield
-
52 Wk
6.3 - 6.55
Mkt Cap
258.4M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.61
Shares
40.3M
Outstanding
-
Total Float
-
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Kiadis Pharma Questions & Anwsers

Q

How do I buy Kiadis Pharma (KIADF) stock?

A

You can purchase shares of Kiadis Pharma (OTC: KIADF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kiadis Pharma's (KIADF) competitors?

A

There are no as such competitors for Kiadis Pharma.

Q

What is the target price for Kiadis Pharma (KIADF) stock?

A

The latest price target for Kiadis Pharma (OTC: KIADF) was reported by Chardan Capital on November 3, 2020. The analyst firm set a price target for 0.00 expecting KIADF to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kiadis Pharma (KIADF)?

A

The stock price for Kiadis Pharma (OTC: KIADF) is $6.41 last updated Mon May 17 2021 19:14:55 GMT+0000 (Coordinated Universal Time).

Q

Does Kiadis Pharma (KIADF) pay a dividend?

A

There are no upcoming dividends for Kiadis Pharma.

Q

When is Kiadis Pharma (OTC:KIADF) reporting earnings?

A

Kiadis Pharma does not have any upcoming earnings scheduled.

Q

Is Kiadis Pharma (KIADF) going to split?

A

There is no upcoming split for Kiadis Pharma.

Q

What sector and industry does Kiadis Pharma (KIADF) operate in?

A

Kiadis Pharma is in the sector and industry. They are listed on the OTC.